Maryland’s coronavirus disease 2019 (COVID-19) task force on vulnerable populations leveraged data on social determinants of health to rapidly pinpoint populations most at risk of severe COVID-19 complications.
Ten months into the coronavirus disease 2019 (COVID-19) pandemic, some states continue to struggle to keep up with new cases and protect their most vulnerable populations from bearing the brunt of the disease.
However, one state was able to get ahead of the pandemic early on and, through public-private partnerships, secured immediate care for hundreds of the highest risk individuals within weeks. On this episode of Managed Care Cast, we speak with Susan Mani, MD, the chief population health officer for LifeBridge Health, and Trenor Williams, MD, the chief executive officer and co-founder of Socially Determined.
Together, Mani and Williams lay out how Maryland’s COVID-19 task force on vulnerable populations was able to leverage data on social determinants of health and analytics to rapidly pinpoint populations most at risk of severe COVID-19 complications and optimize preventive and treatment measures.
Listen above or through one of these podcast services:
Read more about social determinants of health and populations vulnerable to COVID-19:
PwC Report Urges Action to Tackle Social Determinants of Health
Dr Susan Mani: How to Ensure Scalability, Sustainability of SDOH Initiatives
Pandemic Brings Racial, Economic Healthcare Disparities Into Focus
Medicare Claims Data Further Highlight Pandemic's Toll on Racial Minorities
Perioperative Nivolumab Boosts NSCLC Survival: CheckMate 77T Trial
May 16th 2024This interim analysis of the CheckMate 77T trial, outcomes were compared between adult patients receiving neoadjuvant nivolumab plus chemotherapy or neoadjuvant chemotherapy plus placebo for resectable non–small cell lung cancer (NSCLC).
Read More
Decitabine, Venetoclax Combo Boosts Survival in Patients With AML and MDS
May 16th 2024Study findings demonstrate that combining decitabine with venetoclax enhances molecular response rates in patients with acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS), correlating strongly with improved clinical outcomes and overall survival.
Read More
Frameworks for Advancing Health Equity: Urban Health Outreach
May 9th 2024In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.
Listen
Atypical Marker Expression in T-Cell Acute Lymphoblastic Leukemia/Lymphoma
May 15th 2024Two unique case reports highlight the diagnostic challenges and critical importance of comprehensive immunophenotyping in cases of T-cell acute lymphoblastic leukemia/lymphoma that present without typical immaturity markers but with rare γδ T-cell receptor expression.
Read More
After the ACA Expanded Health Care Access, 2024 Elections May See Voters Demand Affordability
May 15th 2024At the spring conference of the New Jersey Health Care Quality Institute, speakers discussed how health policy, affordability, and transparency may play a role in voters’ decisions.
Read More